ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Aclaris Announces Proposed Public Offering of Common Stock
June 09, 2021Aclaris Therapeutics, Inc.,today announced that it intends to offer and sell, subject to market conditions, $75 million in shares of its common stock in an underwritten public offering. -
FDA promo police spank Aclaris for misleading info in Eskata video
July 09, 2019Aclaris Therapeutics is the latest pharma on the hot seat with the FDA’s promotion enforcers. In this case, the Office of Prescription Drug Promotion is targeting a DTC video it deems misleading. -
Aclaris Therapeutics Submits IND for RA Treatment
June 14, 2019If the IND is allowed by the FDA, Aclaris plans to initiate a Phase 1 trial of ATI-450, an oral MK2 inhibitor in 2H19
Pharma Sources Insight January 2025
